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Abstract
Background: Mesenchymal stem cells (MSCs) hold great promise for the treatment of difficult diseases. As MSCs represent a
rare cell population, ex vivo expansion of MSCs is indispensable to obtain sufficient amounts of cells for therapies and tissue
engineering. However, spontaneous differentiation and aging of MSCs occur during expansion and the molecular
mechanisms involved have been poorly understood.
Methodology/Principal Findings: Human MSCs in early and late passages were examined for their expression of genes
involved in osteogenesis to determine their spontaneous differentiation towards osteoblasts in vitro, and of genes involved
in self-renewal and proliferation for multipotent differentiation potential. In parallel, promoter DNA methylation and
hostone H3 acetylation levels were determined. We found that MSCs underwent aging and spontaneous osteogenic
differentiation upon regular culture expansion, with progressive downregulation of TERT and upregulation of osteogenic
genes such as Runx2 and ALP. Meanwhile, the expression of genes associated with stem cell self-renewal such as Oct4 and
Sox2 declined markedly. Notably, the altered expression of these genes were closely associated with epigenetic
dysregulation of histone H3 acetylation in K9 and K14, but not with methylation of CpG islands in the promoter regions of
most of these genes. bFGF promoted MSC proliferation and suppressed its spontaneous osteogenic differentiation, with
corresponding changes in histone H3 acetylation in TERT, Oct4, Sox2, Runx2 and ALP genes.
Conclusions/Significance: Our results indicate that histone H3 acetylation, which can be modulated by extrinsic signals,
plays a key role in regulating MSC aging and differentiation.
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Introduction
Mesenchymal stem cells (MSCs) are self-renewing and expandable
stem cells [1,2,3]. In order to compare and contrast study outcomes
from different research groups, the Mesenchymal and Tissue Stem
Cell Committee of the International Society for Cellular Therapy
proposed a minimal criterion to define human MSCs. First, MSCs
must be plastic-adherent when maintained in standard culture
conditions. Second, MSCs must be lineage-negative and express
CD105, CD73 and CD90. Third, MSCs must differentiate to at least
osteoblasts, adipocytes and chondroblasts ex vivo [3].
Increasing evidence has suggested profound therapeutic poten-
tial of MSCs for a variety of diseases such as myocardial infarction
[4,5,6,7], neural diseases [8,9] strokes [10], and wound healing
[11,12]. Moreover, allogeneic MSCs have shown low immunoge-
nicity and immunosuppressive properties [13,14,15]. Due to
encouraging preclinical results, numerous clinical trials for a
variety of diseases are underway [16,17,18,19,20].
MSCs represent as a rare cell population in the bone marrow
(BM) and other tissues. BM is the major source of MSCs, where
they represent only approximately 0.001% to 0.01% of the
nucleated cells, about 10-fold less abundant than hematopoietic
stem cells (HSCs). Therefore, ex vivo expansion of MSCs is an
indispensable procedure to obtain sufficient amounts of cells for
MSC-based therapies and tissue engineering. MSCs are capable of
proliferating in culture [1,2], and they are genetically stable when
undergoing limited ex vivo expansion [21]. However, recent studies
suggest MSCs age rapidly in culture and undergo considerable
property changes. This has raised concerns over the effect and
safety of MSC-based therapies [22,23]. More importantly, the
molecular mechanisms underlying phonotypical changes of MSCs
during culture expansion are unclear.
In this study, we found that MSCs underwent considerable
epigenetic and gene expressional alterations during culture
expansion, even though the morphological changes are modest.
The expression of osteogenic genes increased progressively with
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genes such as Oct4 and Sox2 declined markedly. In accordance
with these changes were epigenetic dysregulations, with histone
H3 acetylation in particular. Basic fibroblast growth factor (bFGF)
modulated histone H3 acetylation in telomerase reverse transcrip-
tase (TERT), Oct4, Sox2, Runx2 and alkaline phosphatase (ALP)
genes, promoted MSC proliferation and suppressed its spontane-
ous osteogenic differentiation. Ex vivo culture of MSCs also caused
changes in methylation levels in CpG islands in the promoter and
exon 1 regions in most of these genes, but the changes did not
coincide with expressional changes of the corresponding genes.
Therefore, our results suggest that acetylation of histone H3
modulates the expression of critical genes in MSCs, thereby
regulating their behavior.
Results
Characterization of MSCs
Fluorescence activated cell sorting (FACS) analysis of our MSCs
showed that they were negative for lineage cell markers such as
CD34 and CD45, and were strongly positive for CD105, CD73 and
CD90, exhibiting typical immunophenotypic features of MSCs
(Fig. 1). The cells also expressed CD51 and CD61 (Fig. 1). After
induction in appropriate media, MSCs differentiated into adipo-
cytes (Fig. 2B), osteoblasts (Fig. 2D) and chondrocytes (Fig. 2F).
Spontaneous differentiation and downregulation of
pluripotent genes in MSCs during culture expansion
Cultured in growth medium, MSCs underwent modest but
progressive morphological changes with successive passages. The
cells became larger and fatter in general (Fig. 3A and B).
Meanwhile, a small portion of cells became extremely larger and
flatter, which were similar to osteoblasts in morphology and positive
for ALP stain (Fig. 3C), indicating the presence of spontaneous
differentiation of MSCs into osteoblasts. In accordance with
changes in morphology, the expression of genes associated with
osteogenesis such as collagen type I, ALP, bone sialoprotein (BSP),
osteocalcin (OCN) and osteopontin (OPN) increased progressively
with successive cell passages (Fig. 3D), while the expression of genes
associated with stem cell pluripotency and proliferation decreased
markedly, which included Oct4, Sox2, Nanog, REX1, CD133 and
TERT (Fig. 4A and C; Fig. 5B and E).
Epigenetic dysregulation of MSCs
Previous studies have shown that MSCs are genetically stable after
limited expansion [21]. So we investigated whether MSCs underwent
epigenetic changes during culture expansion, with an emphasis on
promoter DNA methylation and histone H3 acetylation. We found
dramatic alterations in histone H3 acetylation in K 9 and K14 in
TERT, Sox2, Oct4, Runx2 and ALP genes in replicating MSCs when
comparing passage 1 with passage 6 MSCs (Fig. 4B; Fig. 5A, 5D,
6A and 6D). Downregulation in the expression of TERT, Sox2 and
Oct4 genes were closely associated with decreases in H3 acetylation
levels in the promoter regions of the corresponding genes (Fig. 4B and
4C; Fig. 5A, B, D and E). Meanwhile, upregulated expression of
Runx2 and ALP genes was accompanied by increases in H3
acetylation levels in the promoter of the corresponding genes
( F i g .6 A ,B ,Da n dE ) .W ea l s oe x a m i n e dD N Am e t h y l a t i o ni nC p G
islands in the promoter and exon 1 regions of these genes in parallel.
Our results showed alterations in methylation levels in most of these
genes in MSCs undergoing culture expansion, but they did not
correlate to expressional changes of the corresponding genes except for
A L P( F i g .4 Ca n dD ;F i g .5 B ,C ,Ea n dF ;F i g .6B ,C ,Ea n dF ) .
bFGF promotes MSC proliferation, suppresses MSC
spontaneous differentiation and regulates histone
acetylation
We proposed that alterations in MSC properties were largely
caused by extrinsic signals and tested whether bFGF helped maintain
the primitive features of MSCs. We found that MSCs grown in
growth medium supplemented with bFGF had a 10 fold increase in
cumulative cell number by passage 4 compared to MSCs grown in
growth medium alone (Fig. 7A). When passage 6 MSCs grown in
growth mediumor ingrowth mediumsupplemented with bFGF were
modestly induced in osteogenic induction medium for 3 days, the
later had significantly less mineral deposition than the former (Fig. 7B
and C), indicating that bFGF suppressed spontaneous differentiation
of MSCs towards osteoblasts, but retained the potency of
osteogenesis.
We then analyzed the influence of bFGF on epigenetic
regulation in MSCs. We found that bFGF significantly suppressed
alterations in histone H3 acetylation caused by ex vivo culture in
TERT, Sox2, Oct4, Runx2 and ALP genes (Fig. 4 to 6), and this
effect highly coincided with the effects of bFGF on MSC
proliferation and spontaneous differentiation (Fig. 7). Meanwhile,
we also examined DNA methylation in CpG islands in the
promoter and exon 1 regions of these genes in parallel. Our results
showed evident influences of bFGF on DNA methylation levels in
Oct4, Runx2 and ALP, but not in TERT and Sox2 (Fig. 4 to 6).
But these changes in DNA methylation did not correlate to
expressional changes of the genes.
Figure 1. Fluorescence-activated cell sorting (FACS) analysis of MSCs. Passage 3 MSCs were analyzed by FACS after staining with FITC- or
PE-conjugated control isotype IgG (gray peaks) or antibodies against indicated cell surface proteins (filled red or green peaks).
doi:10.1371/journal.pone.0020526.g001
Histone Acetylation in MSC Aging
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Due to encouraging effects of MSCs in tissue repair/regeneration
demonstrated in animal studies, numerous clinical studies on MSC-
based therapies for diverse diseases are underway. However, concerns
over the consequences of altered properties of MSCs after ex vivo
expansion remain. In this study, we found that MSCs underwent
progressive spontaneous differentiation towards osteoblasts in MSCs
undergoing regular culture expansion.
The molecular mechanisms underlying MSC spontaneous differ-
entiation and aging are unclear. Previous studies have indicated that
limited expansion of MSCs does not cause alterations in gene
sequences [21], implying that alterations of MSCs ex vivo are probably
not due to genetic instability. Therefore, in this study, we examined
epigenetic changes in histone H3 acetylation and gene promoter DNA
methylation. We found marked changes in histone H3 acetylation in
K9 and K14 in TERT, Soc2, Oct4, Runx2 and ALP genes in late
passage (P6) MSCs compared to early passage (P1) MSCs, and H3
acetylation levels coincided closely with gene expressional levels and
MSC aging and spontaneous osteogenic differentiation, suggesting that
histone H3 acetylation is an important mechanism in regulating MSC
aging and differentiation. It has been known that posttranslational
histone modifications participate in modulating the structure and
function of chromatin and are critical in regulating gene transcription.
Figure 2. Differentiation of MSCs. Cultured in appropriate induction media, (A & B) MSCs differentiated into adipocytes (after oil red staining, A
represents non-induced and B represents induced), (C & D) osteoblasts (after Alizarin Red S staining, C represents non-induced and D represents
induced), and (E & F) chondrocytes (after Alcian Blue staining, E represents non-induced and F represents induced).
doi:10.1371/journal.pone.0020526.g002
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the N-terminal tail of histone H3 [24]. Acetylation of K9 and K14 in
histone H3 is required for the recruitment of TFIID [25], and TFIID
binding to the promoter causes DNA bending and downstream
translocation of the SWI/SNF-modified nucleosome, thus allowing the
initiation of transcription [26]. It has been found that increases in levels
of promoter histone H3 acetylation at lysine 9 in human hepatocellular
liver carcinoma cells are accompanied with increases in overall gene
expression levels [27]. In this study, we examined representative genes
to reflect behavioral changes in MSCs during culture expansion.
TERT enables cells to divide repeatedly and reduced expression of
TERT is associated with cell aging [28]. Sox2 and Oct4 have long
been known as key regulators of embryonic stem cell (ESC) self-
renewal [29]. Runx2 is a key transcription factor associated with
osteoblast differentiation, and the expression of Runx2 is a milestone
for mesenchymal cells’ commitment to osteoblasts [30,31]. ALP is a
characteristic gene expressed in osteoblasts [32].
Global histone acetylation levels have been examined in two
recent studies. While no significant age related changes were
detected in the global histone modification profiles of 4 histone
core proteins (H2A, H2B, H3, and H4) in monkey BM derived
MSCs in one study [33], genome-wide histone H3-K9 acetylation
levels at gene promoters in human BM-derived MSCs were found
to coincide well with overall mRNA expression levels in another
[34]. These results suggest that MSC aging appears not to be
associated with changes in global histone acetylation level but
likely in gene promoter histone acetylation level. Indeed, in this
study, we identified critical genes in which evident histone H3
modulations occurred in promoters in accordance with MSC
aging, self-renewal and osteogenic differentiation. Our findings
may facilitate the development of novel markers for early detection
of MSC aging and spontaneous differentiation, thereby to ensure
the quality of MSCs for clinical uses.
Recent studies suggest that DNA methylation is an important
mechanism in regulating self-renewal and multipotency of HSCs
and leukemia stem cells by silencing the expression of genes in
differentiation [35]. In this study, we compared DNA methylation
levels in CpG islands in promoter and exon 1 regions of genes
Figure 3. Morphological changes and spontaneous estrogenic differentiation of MSCs. Cultured in growth medium, (A & B) MSCs became
larger and fatter upon expansion, (C) A few cells became extremely larger and flatter and were positive (in red) for alkaline phosphatase (ALP) stain.
(D) Real-Time PCR analysis showed that the expression of genes associated with osteogenesis such as collagen type I (Col I), alkaline phosphatase
(ALP), bone sialoprotein (BSP), osteocalcin (OCN) and osteopontin (OPN) increased progressively with cell passages. P1 to P10 represents MSC
passage number. Induction indicates MSCs after incubation with osteogenic induction medium for 14 days.
doi:10.1371/journal.pone.0020526.g003
Figure 4. Gene expression, histone acetylation and DNA methylation in early and late passage MSCs. (A) Real-Time PCR analysis of the
expression of Nanog, REX1 and CD133 in culture passage (P) 1, passage 6 MSCs cultured in growth medium or passage 6 MSCs growth medium
supplemented with bFGF (P6-bFGF). bFGF treatment started from passage 1 cells. (B) TERT histone H3 acetylation (** P,0.01 versus P1 and P6 in
bFGF-supplemented culture). (C) TERT gene expression (Real-Time PCR analysis) and, (D) DNA methylation in CpG islands in the promoter region of
TERT in passage 1 and 6 MSCs cultured in growth medium versus passage 6 MSCs cultured in growth medium supplemented with bFGF (P6-bFGF).
doi:10.1371/journal.pone.0020526.g004
Histone Acetylation in MSC Aging
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and aging such as TERT and osteogenic differentiation including
Runx2 and ALP in early versus late passage MSCs. To our
surprise, though dysregulations in promoter DNA methylation
exist in most of these genes, only changes in ALP gene coincided
with gene expression levels. We obtained similar results in MSCs
derived from cord tissues (data not shown). Some of our data are
consistent with results published in a previous study, in which
Runx2 was found hypermethylated in MSCs after long term
culture [36]. Moreover, in the same study, a comparative
methylation BeadChip microarray analysis in combination with
cDNA microarray analysis did not reveal a clear correlation
between the degrees of global CpG methylation and the levels of
mRNA expression in long-term culture or aging MSCs [36].
Taken together, these results and ours suggest that dysregulations
in promoter DNA methylation occur to aging MSCs, but may not
coincide with gene expressional changes.
Previous studies suggest that aging and spontaneous differenti-
ation of MSCs ex vivo are likely caused by inappropriate culture
conditions [37,38,39,40]. The physiological niche of MSCs is
Figure 5. Multipotent gene expression, histone acetylation and DNA methylation in early and late passage MSCs. Gene expression,
histone acetylation and DNA methylation. (A) Sox2 and (D) Oct4 histone H3 acetylation (** P,0.01); (B) Sox2 and (E) Oct4 gene expression (Real-Time
PCR analysis), and (C) DNA methylation in CpG islands in the promoter region and exon 1 region of Sox2 and (F) Oct in passage (P) 1 and 6 MSCs
cultured in growth medium versus passage 6 MSCs cultured in growth medium supplemented with bFGF (P6-bFGF).
doi:10.1371/journal.pone.0020526.g005
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osteoblasts and facilitate their self-renewal. We proposed that
potent extrinsic signals that alter MSC behavior will change the
epigenetic status of corresponding genes. As a proof of concept, we
examined the influence of bFGF, a potent cytokine that has been
used as a supplement to MSC culture [41], on the histone
acetylation and DNA methylation levels in MSCs. We found that
supplementation of bFGF to the growth medium significantly
promoted MSC proliferation and suppressed their spontaneous
differentiation towards osteoblasts. Moreover, in accordance with
these changes, bFGF treatment delayed the downregulation of
TERT, Sox2 and Oct4, and suppressed the upregulation of
Figure 6. Osteogenic gene expression, histone acetylation and DNA methylation in early and late passage MSCs. (A) Runx2 and (D)
ALP histone H3 acetylation (** P,0.01), (B) Runx2 and (E) ALP gene expression (Real-Time PCR analysis), and (C) DNA methylation in CpG islands in
the promoter region of Runx2 and (F) in the in the promoter region and exon 1 region of ALP in passage (P) 1 and 6 MSCs cultured in growth medium
versus passage 6 MSCs cultured in growth medium supplemented with bFGF (P6-bFGF).
doi:10.1371/journal.pone.0020526.g006
Histone Acetylation in MSC Aging
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changes of these genes were corresponding alterations in histone
H3-K9 and K14 acetylation levels, but not in promoter DNA
methylation levels. bFGF has been known as an essential
component of the regulatory niche in maintaining the pluripoten-
cy of ESCs, and inhibition of FGF signal pathway causes
differentiation of ESCs [42,43]. However, the mechanisms
underlying the effect of bFGF in stem cell self-renewal are not
fully understood. Our results show that bFGF regulates promoter
histone H3 acetylation and consequently the expression of genes
critical for stem cell self-renewal and osteogenic differentiation.
Materials and Methods
Cell isolation and culture
MSCs were isolated from human placenta as described
previously [44,45]. Briefly, term (38–40 weeks’ gestation) placentas
from healthy donors were harvested with written informed consent
and the procedure was approved by the Ethics Committee of Xili
Hospital. The placental tissue was washed several times with cold
phosphate-buffered saline (PBS) and then mechanically minced
and enzymatically digested with 0.25% trypsin-EDTA for
10 minutes at 37uC in a water bath. The digest was subsequently
pelleted by centrifugation and resuspended in growth medium
consisting of Dulbecco’s modified Eagle’s medium (DMEM,
Gibco-Invitrogen) supplemented with 10% fetal bovine serum
(FBS; Gibco-Invitrogen) and antibiotics. Cells were seeded on
uncoated polystyrene dishes and incubated in growth medium at
37uC with 5% CO2. Medium was replaced every 2 days to reach
80% confluence. The cells that were lifted by incubating with
0.25% trypsin/EDTA for 2 min at 37uC were collected. In some
cultures as indicated bFGF (R&D) at 5 ng/ml was added to the
growth medium.
Flow cytometry
MSCs were analyzed by flow cytometry analysis for immuno-
phenotype [11]. Passage 3 cells were resuspended in PBS
containing 1% bovine serum albumin (BSA) at 10
6/ml. 100 mL
cell aliquots were incubated with fluorescein isothiocyanate
(FITC)- or phycoerythrin (PE)-conjugated monoclonal antibodies
against CD73 (eBioscience), CD105 (endoglin), CD90, CD45,
CD51, CD61 and CD34 (BioLegend), or control isotype IgG on
ice for 30 minutes. 10,000 events were analyzed by flow cytometry
(Becton Dickinson) using Cell Quest software.
MSC differentiation assays
Passage 4 MSCs were incubated to differentiate into adipocytes,
osteoblasts and chondrocytes in corresponding induction medium
as previously described [1,11]. After 3 weeks of culture with
adipogenic induction medium containing 10
26 M dexametha-
sone, 10 mg/mL insulin, and 100 mg/mL 3-isobutyl-L-methylxan-
tine (Sigma), cells were stained with Oil Red-O to detect lipid.
Osteogenic medium contained 10
27 M dexamethasone, 50 mg/ml
ascorbic acid, and 10 mM b-glycerophosphate (Sigma). Cultures
at 3 weeks were stained using Alzarin Red for calcium deposition.
For chondrocyte differentiation, MSC were cultured in DMEM
(high glucose) containing 10
27 M dexamethasone, 50 mg/ml
ascorbate-2-phosphate, 100 mg/ml pyruvate (Sigma), 10 ng/ml
TGF-b1 (R&D Systems) and 50 mg/ml ITS+Premix (BD
Biosciences, 6.25 mg/ml insulin, 6.25 mg/ml transferrin,
6.25 ng/ml selenious acid, 1.25 mg/ml bovine serum albumin,
and 5.35 mg/ml linoleic acid). Cultures at 3 weeks were fixed and
stained for alcian blue (Sigma).
RNA extraction and Real-Time PCR
Total RNA was extracted from MSCs with TRIzol (Invitrogen)
following the manufacturer’s instructions. First-strand cDNA was
prepared by reverse transcription with Superscript II reverse
transcriptase (Invitrogen) and oligo(dT) primers and stored at
220uC. Real-Time PCR was performed using SYBRH Premix Ex
Taq
TM II (TaKaRa) on an ABI 7300 QPCR System. As an
internal control, levels of glyceraldehyde-3- phosphate dehydro-
genase (GAPDH) were quantified in parallel with target genes.
Normalization and fold changes were calculated using the DDCt
method [11]. Primer sets are listed in Table 1.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assay was performed
using an Acetyl-Histone H3 Immunoprecipitation Assay Kit
(Millipore) following the manufacturer’s protocol [46]. 1610
6 cells
were used for each reaction. Histone acetylation was determined
using specific antibodies against acetylated histone H3 at lysines 9
(K9) and 14 (K14), respectively (included in the kit). After chromatin
immunoprecipitation, DNA was extracted with a standard procedure
(phenol/chloroform/isoamilic alcohol 25:24:1), and subsequently
measured by quantitative fluorescent PCR analysis using SYBRH
Premix Ex Taq
TM II (TaKaRa) on an ABI 7300 QPCR System.
Primer targets were within 500 bp upstream of gene transcription
start site and primer sets were as follows: TERT forward 59-
GGCTCCCAGTGGATTCGC-39,r e v e r s e5 9-GGAGGCGGAG-
CTGGAAGG-39;S o x 2f o r w a r d5 9-AGTTGGACAGGGAGAT-
GGC-39, reverse 59-AACCTTCCTTGCTTCCACG-39;O c t 4f o r -
ward 59-CTTCCACAGACACCATTGCC-39, reverse 59-AGTCC-
CACCCACTAGCCTTG-39;R u n x 2f o r w a r d5 9-GCTTCAATCC-
TTTCCTACAAAG-39,r e v e r s e5 9-CGTGTGCAGTTTCCGAC-
AG-39;A L Pfo r w a rd5 9- TGTTGACAGACACAGAGACAGACG-
Figure 7. Effects of bFGF on MSC proliferation and spontaneous differentiation. (A) Growth curves of MSCs cultured in growth medium
(control) and in growth medium supplemented with bFGF (bFGF). (B) MSCs cultured in growth medium (control) or in growth medium supplemented
with bFGF (bFGF) for 3 days after Alizarin Red S staining. (C) Mean proportion of Alizarin Red S positive areas per field after quantification of 4
randomly selected fields (** P,0.01).
doi:10.1371/journal.pone.0020526.g007
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analyzed using Percent Input Method (Invitrogen) followed the
instruction.
Genomic DNA extraction and bisulfite sequencing
MSCs were lysed in a lysis buffer containing 0.5% SDS, 0.1 M
EDTA, 10 mM Tris–HCl, pH 8.0, and 100 ng/ml proteinase K,
and incubated at 55uC overnight. Genomic DNA was purified by
phenol/chloroform extraction. DNA (2 mg) from each sample was
bisulfite converted using an EZ DNA Methylation-Gold
TM Kit
(Zymo research Corporation, Orange, CA, USA). To identify the
methylation pattern of the genes, primers were designed to amplify
the promoter and/or exon 1 region. The sequences of primers are
as follows. TERT forward 59- GGGATGTGATTAGATGTTC-
GGTT-39, reverse 59- ACCCAAAACTACCTCCAAAT-39 (cov-
er region 2891,2463); Sox2 forward 59- GATTTTAATAA-
GAGAGTGGAAGGAA-39, reverse 59- CAAAACCAACCCTA-
ACATTTT-39 (cover region 2421,+21); Oct4 forward 59-
GTTAGAGGTTAAGGTTAGTGGGTGGGAT-39, reverse AA-
CACTAACCCCACTCCAACCTAAAAC-39 (cover region 257-
,+311); Runx2 forward 59-GGGGTTAGAGTTTTTTTTTG-
TG-39, reverse 59- ACAAACACTAACCCCAAACC-39 (cover
region 2384,2101); ALP forward 59-GGTTGAATTTTAA-
TGGTAGGGT-39, reverse 59- CACCAAAAAAAACTCAATC-
A-39 (+240,+538). Touch down PCR was then carried out. The
amplified products were gel-purified, and cloned into pMD-18T
vectors (Takara). After that the recombinant plasmid was
transformed into E. coli JM109. Seven to eleven clones for each
gene were collected for sequencing [47].
Statistical analysis
All values are expressed as mean 6 SD. Student’s paired t test
was performed for comparison of data of paired samples and
ANOVA was used for multiple group comparisons. A probability
(P) value , 0.05 was considered significant.
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Osteocalcin 59-GAAGCCCAGCGGTGCA-39 59-CACTACCTCGCTGCCCTCC-39
Osteopontin 59-CTCAGGCCAGTTGCAGCC-39 59-CAAAAGCAAATCACTGCAATTCTC-39
ALP 59-GACCCTTGACCCCCACAAT-39 59-GCTCGTACTGCATGTCCCCT-39
BSP 59-GCAGTAGTGACTCATCCGAAGAA-39 59-GCCTCAGAGTCTTCATCTTCATTC-39
GAPDH 59-GCACCGTCAAGGCTGAGAAC-39 59-TGGTGAAGACGCCAGTGGA-39
ALP, alkaline phosphatase; BSP, bone sialoprotein.
doi:10.1371/journal.pone.0020526.t001
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